Advertisement
‘We are overjoyed’: Chinese mRNA researchers celebrate Nobel win for field’s pioneers
- It will take up to a decade for China to catch up with global developments in the technology, which is the foundation of Covid-19 vaccines, scientist says
- Key areas for improvement are storage, side effects and shelf life
Reading Time:4 minutes
Why you can trust SCMP
27
Chinese scientists working on mRNA technology, the foundation of Covid-19 vaccines, are hopeful of a boost to their field following a Nobel Prize win for two pioneers in the area.
Hungarian-born Katalin Kariko and American Drew Weissman won the Nobel Prize for medicine this year for work that paved the way for groundbreaking vaccines against the coronavirus.
Billions of mRNA-based Pfizer/BioNTech and Moderna doses were administered and together with other Covid-19 vaccines, “saved millions of lives and prevented severe disease in many more”, the Nobel committee said.
Advertisement
Now the race is on in China – and around the world – to build on that work to improve the technology’s stability, extend its shelf life and make storage easier above ultra-low temperatures. Researchers are also aiming to expand applications to cancer and other diseases.
03:16
Nobel Medicine Prize given to 2 scientists for mRNA research that enabled Covid vaccine
Nobel Medicine Prize given to 2 scientists for mRNA research that enabled Covid vaccine
Unlike traditional vaccines that introduce a weakened or inactivated virus into the body, messenger RNA uses a molecule that teaches human cells how to make a protein, which triggers an immune response in the body by producing antibodies.
Advertisement
Advertisement
Select Voice
Choose your listening speed
Get through articles 2x faster
1.25x
250 WPM
Slow
Average
Fast
1.25x